DongKook Pharmaceutical Co., Ltd. (086450.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap761.43B
Enterprise Value781.49B
P/E Ratio10.46
PEG Ratio0.41
Price/Sales Ratio0.82
Price/Book Ratio1.15
Enterprise/Revenue0.81
Enterprise/EBITDA5.85

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.11

Income Statement

Revenue926.88B
Revenue/Share21,715.33
Gross Profit501.6B
EBITDA127.97B
Net Income66.02B
Diluted EPS1,475

Balance Sheet

Total Cash118.53B
Total Cash/Share2,627.57
Total Debt67.26B
Total Debt/Equity0.1
Current Ratio2.05
Book Value Per Share17,702.59

Price History

52-Week Change3.49
52-Week High31,250
52-Week Low16,260
Moving Average 50 Days18,826
Moving Average 200 Days19,684.75

Statistics

Average Volume379,298
Shares Outstanding45.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate200
Trailing Annual Dividend Yield1.13
Payout Ratio0.12
Last Split Factor5:1
Last Split DateAugust 24, 2020
AD